NASDAQ: SPRB - Spruce Biosciences, Inc.

Yield per half year: -27.75%
Dividend yield: 0.00%
Sector: Healthcare

Spruce Biosciences, Inc.

0.95080.95080.84550.84550.74020.74020.63490.63490.52960.52960.42430.42430.31900.3190May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.09 -100% -6.25 -100%
P/S 9.47 33.5 -71.74%
P/BV 1.25 4.61 -72.95%
P/FCF -2.88 39.66 -107.25%
Ev/Ebitda -0.0727 -19.46 -99.63%
Ev/S 0.3742 22.56 -98.34%
Ev/FCF -0.1134 45.47 -100.25%
E/P -0.5007 0.0172 -3003.05%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-514.65 -14.42 3468.83% -823.06 -37.47%
ROE -62.63 9.01 -795.11%
ROA -46.1 0.0151 -304495.5%
ROIC -34.49 7.63 -551.77%
ROS -474.96 -26.5 1691.98%
ROCE -67.96 13.75 -594.15%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0691 -3.73 -98.15% -0.0993 -30.4%
Nеt Debt/Ebitda 1.77 -3.19 -155.32%
Debt/Ratio 0.0345 0.1777 -80.57%
Debt/Equity 0.0429 1.57 -97.27%
Debt/Net Income -0.0749 0.8429 -108.89%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5467 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2387 -100%
Average dividend growth 0 1.55 -100%
Average percentage for 5 years 0 0.4967 -100%
Average percentage for payments 0 43.73 -100%
Difference from average difference in sector -0.5467

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
413.7 73.67 461.56%
Growth impulse Ebitda in 5 years 261.71 15.28 1612.76%
Growth impulse Net Income in 5 years 268.61 -33.08 -912%
Growth impulse FCF in 5 years 156.02 -6.99 -2332.05%
Growth impulse EPS in 5 years -12.98 -59.11 -78.04%
IP Score
4.48/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription